Gene polymorphism in TOLL-like receptor and associated diseases
- Authors: Dvornikova K.A1, Bystrova E.Y.1, Platonova O.N1, Nozdrachev A.D1
-
Affiliations:
- I.P. Pavlov Institute of Physiology, RAS
- Issue: Vol 17, No 6 (2019)
- Pages: 5-12
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113165
- DOI: https://doi.org/10.29296/24999490-2019-06-02
- ID: 113165
Cite item
Abstract
Full Text
About the authors
K. A Dvornikova
I.P. Pavlov Institute of Physiology, RAS
Email: 691442@gmail.com
Makarova Emb., 6, Saint-Petersburg, 199034, Russian Federation
E. Yu Bystrova
I.P. Pavlov Institute of Physiology, RAS
Email: 691442@gmail.com
Makarova Emb., 6, Saint-Petersburg, 199034, Russian Federation
O. N Platonova
I.P. Pavlov Institute of Physiology, RAS
Email: 691442@gmail.com
Makarova Emb., 6, Saint-Petersburg, 199034, Russian Federation
A. D Nozdrachev
I.P. Pavlov Institute of Physiology, RAS
Email: 691442@gmail.com
Makarova Emb., 6, Saint-Petersburg, 199034, Russian Federation
References
- Hold G.L., Berry S., Saunders K.A. et al. The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of TRIF dependent genes. PLoS. One. 2014; 9: e111460. https://doi.org/10.1371/journal. pone.0111460
- Ashton K.A., Proietto A., Otton G. et al. Tolllike receptor (TLR) and nucleosome-bind-ing oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer. 2010; 10: 382. https://doi. org/10.1186/1471-2407-10-382
- Trejo-de la O., Hernandez-Sancen P, Maldonado-Bernal C. Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer. Genes and Immunity. 2014; 15: 199-209. https://doi.org/10.1038/ gene.2014.10
- El-Omar E.M., Hold G.L. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene. 2008; 27: 244-52. https://doi. org/10.1038/sj.onc.1210912
- Medvedev A.E. Toll-Like Receptor Polymorphisms, Inflammatory and Infectious Diseases, Allergies, and Cancer. Journal of Interferon & Cytokine Research. 2013; 33 (9): 467-84. https://doi.org/10.1089/jir.2012.0140
- Филиппова Л.В., Быстрова Е.Ю., Малышев Ф.С., Платонова О.Н., Ноздрачев А.Д. Экспрессия паттерн-распознающих рецепторов ноцицептивными метасимпатическими нейронами. Бюллетень экспериментальной биологии и медицины. 2015; 159 (2): 209-13.
- Филиппова Л.В., Малышев Ф.С., Быкова А.А., Ноздрачев А.Д. Экспрессия толл-подобных рецепторов 4 в нервных сплетениях двенадцатиперстной, тощей и ободочной кишки крысы. Доклады Академии наук. 2012; 445 (3): 353
- Шпанская А.А., Платонова О.Н., Быстрова Е.Ю. Влияние ингибирования рецептора TLR4 на экспрессию ноцицептивного рецептора TRPV1 в энтеральных нейронах толстой кишки крысы. В книге: Современные аспекты интегративной физиологии. Материалы Всероссийской молодежной конференции с международным участием. Институт физиологии им. И.П. Павлова РАН. 2018: 120-1
- Бережная Н.М. Toll-like рецепторы и онкогенез. Онкология. 2013; 15 (2): 76-87
- Chuang T., Ulevitch R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta. 2001; 1518: 157-61. https://doi.org/10.1016/S0167-4781(00)00289-X.
- Du X., Poltorak A., Wei Y, Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Network. 2000; 11: 362-71.
- Hold G.L., Smith M.G., McLean M.H. et al. Innate immune response gene polymorphisms and their role in H-pylori-induced gastric cancer. Gastroenterology 2006; 130 (A61).
- Pirie F.J., Pegoraro R., Motala A.A. et al. Toll-like receptor 3 gene polymorphisms in South African blacks with type 1 diabetes. Tissue Antigens. 2005; 66: 125-30. https:// doi.org/10.1111/j.1399-0039.2005.00454.x
- Theodoropoulos G.E., Saridakis V, Karanta-nos T. et al. Toll-like receptor gene polymorphisms may confer increased susceptibility to breast cancer development. Breast. 2012; 21: 534-8. https://doi.org/10.10Wj. breast.2012.04.001
- Ueta M., Sotozono C., Inatomi T. et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br. J. Ophthalmol. 2007; 91: 9625. https://doi.org/10.1136/bjo.2006.113449
- Понасенко А.В., Кутихин А.Г., Хуторная М.В., Южалин А.Е., Рутковская Н.В., Головкин А.С., Барбараш Л.С. Связь полиморфизмов генов системы TLR с риском развития инфекционного эндокардита. Медицина в Кузбассе. 2015; 4: 4-10.
- Johnson C.M., Lyle E.A., Omueti K.O. et al. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy J. Immunol. 2007; 178: 7520-4. https://doi.org/10.4049/jimmu-nol.178.12.7520
- Hawn T.R., Misch E.A., Dunstan S.J. et al. A common human TLR1 polymorphism regulates the innate immune response to lipo-peptides. Eur. J. Immunol. 2007; 37: 2280-9. https://doi.org/10.1002/eji.200737034
- Franchimont D., Vermeire S., El Housni H. et al. The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut. 2004; 53: 987-92. https://doi.org/10.1136/ gut.2004.051383
- Hold G.L., Rabkin C.S., Chow WH. et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007; 132: 905-12. https://doi.org/10.1053/]. gastro.2006.12.026
- Kiechl S., Lorenz E., Reindl M. et al. Toll-like receptor 4 polymorphisms and athero-genesis. N. Engl. J. Med. 2002; 347: 185-92. https://doi.org/10.1056/NEJMoa012673
- Ohto U., Yamakawa N., Akashi-Takamura S. et al. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. J. Biol. Chem. 2012; 287: 40611-7. https://doi.org/10.1074/jbc.M112.404608
- Bochud P.Y., Hersberger M., Taffe P et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS. 2007; 21: 441-6. https://doi. org/10.1097/QAD.0b013e328012b8ac
- Mockenhaupt F.P., Hamann L., von Gaertner C. et al. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy J. Infect. Dis. 2006; 194: 184-8. https://doi.org/10.1086/505152.
- Pandey S., Mittal B., Srivastava M. et al. Evaluation of Toll-like receptor 3 (c.1377C/T) and 9 (G2848A) gene polymorphism in cervical cancer susceptibility. Mol. Biol. Rep. 2011; 38: 4715-21. https:// doi.org/10.1007/s11033-010-0607-z
- Su B., Ceponis PJ., Lebel S. et al. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect. Immun. 2003; 71: 3496-502. https:// doi.org/10.1128/IAI.71.6.3496-3502.2003
- Pasare C., Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 2005; 560; 11-8. https://doi. org/10.1016/j.micinf.2004.08.018
- Akira S., Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004; 4: 499-511. https://doi.org/10.1038/nri1391
- Chow J.C., Young D.W, Golenbock D.T. et al. Toll-like receptor-4 mediates lipopoly-saccharide-induced signal transduction. J. Biol. Chem. 1999; 274: 10689-92. https:// doi.org/10.1074/jbc.274.16.10689
- Takeda K., Akira S. Toll-like receptors in innate immunity. Int. Immunol. 2005; 17: 1-14. https://doi.org/10.1093/intimm/dxh186
- Hold G.L., Smith M.G., McColl K.E., El-Omar E.M. A functional Toll-like receptor 4 polymorphism increases the risk of H. pylori-induced pre-malignant changes in the stomach. Gastroenterology. 2003; 124: 18-25.
- Kato I., Canzian F., Plummer M. et al. Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig. Dis. Sci. 2007; 52: 254-61.
- Arbour N.C., Lorenz E., Schutte B.C. et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000; 25: 187-91. https://doi. org/10.1038/76048
- Lorenz E., Frees K.L., Schwartz D.A. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques. 2001; 31: 22-4. https://doi.org/10.2144/01311bm01
- Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gramnegative septic shock. Arch. Intern. Med. 2002; 162: 1028-32. https://doi.org/10.1001/archinte.162.9.1028
- Higgins S.C., Lavelle E.C., McCann C. et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology J. Immunol. 2003; 171: 3119-27. https://doi. org/10.4049/jimmunol.171.6.3119
- Albiger B., Dahlberg S., Henriques-Normark B., Normark S. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. J. Intern. Med. 2007; 261: 511-28. https:// doi.org/10.1111/j.1365-2796.2007.01821.x
- Peek Jr. R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer. 2002; 2: 28-37. https://doi.org/10.1038/nrc703
- Savage S.A., Hou L., Lissowska J. et al. Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population. Cancer Epidemiol. Biomarkers Prev. 2006; 15: 589-91. https://doi. org/10.1158/1055-9965.EPI-05-0887
- Segal E.D., Lange C., Covacci A. et al. Induction of host signal transduction pathways by Helicobacter pylori. Proc. Natl. Acad. Sci. USA. 1997; 94: 7595-9. https:// doi.org/10.1073/pnas.94.14.7595
- Suerbaum S., Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 2002; 347: 1175-86. https://doi.org/10.1056/NEJM-ra020542
- Pandey N., Chauhan A., Neeraj J. TLR4 Polymorphisms and Expression in Solid Cancers. Molecular Diagnosis & Therapy 2018; 22: 683-702. https://doi.org/10.1007/ s40291-018-0361-9
- Sanduleanu S., Jonkers D., De Bruine A. et al. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment. Pharmacol. Ther. 2001; 15: 1163-75. https://doi.org/10.1046Zj.1365-2036.2001.01029.x
- Wu M.S., Cheng T.Y., Shun C.T. et al. Functional polymorphisms of CD14 and Toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies. Hepato-Gastroenterology. 2006; 53: 807-10.
- Junjie X., Songyao J., Minmin S. et al. The association between Toll-like receptor single-nucleotide polymorphism and hepatocellular carcinoma susceptibility. BMC Cancer. 2012; 12: 57. https://doi. org/10.1186/1471-2407-12-57
- Yang C.A., Scheibenbogen C., Bauer S. et al. A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell INF-g production and is associated with Helicobacter pylori-induced gastric disease. Helicobacter. 2013; 18: 13-21.
- Omueti K.O., Mazur D.J., Thompson K.S. et al. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J. Immunol. 2007; 178: 6387-94. https://doi. org/10.4049/jimmunol.178.10.6387
- Sun J., Wiklund F., Zheng S.L. et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J. Natl. Cancer Inst. 2005; 97: 525-32. https://doi.org/10.1093/jnci/dji070
- Pierik M., Joossens S., Van Steen K. et al. Tolllike receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel. Dis. 2006; 12: 1-8.